23andMe Holding Co., a leading human genetics and biotechnology company, has initiated voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri (the “Court”) to facilitate a sale process to maximize the value...
Read Story
March 24, 2025, 08:12 AM
|
Sorrento Therapeutics, a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced that the U.S. Bankruptcy Court for the Southern District of Texas granted...
Read Story
March 30, 2023, 07:00 AM
|